Additional information
| Industry |
|---|
Description
Corporate Real Estate Management (CREM) has faced several challenges in recent years. Globalization, international competition, demographic change, innovation, new workplace models, and – at the forefront – digitalization have changed the Corporate Real Estate world significantly. Now, the COVID-19 crisis has disrupted the Real Estate environment with travel bans, office closures, split-teams and a step change in remote work. Regardless of whether or not pandemics break out more regularly in the future, some of the changes made to cope with this unprecedented situation are likely to wholly or partly become permanent features of our work lives. We may even be on the cusp of an evolution in the way we work and how we utilise Real Estate for business.
CYLAD Consulting has explored how CREM can be utilized as a short-term mitigation lever during the crisis and contribute to a faster business recovery mid-term. We have also hypothesized which structural changes could be instituted in the long run as part of a smart operating model, to secure the health and safety of employees and maintain business resilience.
Only logged in customers who have purchased this product may leave a review.
You may also like
-
Axbility ConsultingBefore starting an S2P project, it is necessary to be aware that data related topics are crucial to ensure a proper operation of the solution. Our clients often do not enough focus on data issues and do not consider data as one of the pillars to succeed in implementing their S2P project.
12 Recommendation to Implement a Source-To-Pay Solution
$0.00 Axbility Consulting
-
LEK
As the construction industry starts its long climb up from the greatest collapse in recent history, companies are looking to repair the damage done by anxious suppliers who ceded margins to (unsuccessfully) maintain volumes. While this dynamic is perhaps most acute in the building materials markets, it is certainly not unique and can be seen across a wide range of commodity and manufacturing sectors.
Rethinking Pricing Strategies in Commoditized Markets: Network-based Best Alternative Pricing
$0.00 LEK
-
LEK
Artificial intelligence (AI) has the potential to transform the pharmaceutical industry. Each of the major pharma players is investing in the technology at some level, and there are a growing number of applications that address target and drug discovery, preclinical and clinical development, and postapproval activities.
Artificial Intelligence in Life Sciences
$0.00 LEK
Trouble with Conavigo
Trouble with Conavigo?
Contact our support team if you have trouble with the search results, your account, or your message box. We are here to help.
Ads Customers
Ads Consultants
Ads Students
Reviews
There are no reviews yet.